Ardent Health, Inc.
ARDT- Exchange
- NYSE
- Industry
- Services-General Medical & Surgical Hospitals, NEC
- SEC CIK
- 0001756655
No open-market purchases or sales by Ardent Health, Inc. insiders were filed in the last 90 days; 138 institutions reported holding it in 13F filings for Q2 2026, worth $1.07B in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 10:58 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 |
|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 |
| Filing | 10-K | 10-K |
| Reported | Mar 4, 2026 | Jan 13, 2025 |
| Revenue | $6.32B | $5.97B |
| Selling, general and administrative | $140.8M | $132.4M |
| Income tax | $56.2M | $63.4M |
| Net income | $135.8M | $210.3M |
| EPS, basic | $0.96 | $1.59 |
| EPS, diluted | $0.96 | $1.58 |
| Weighted shares, basic | 140.8M | 132.4M |
| Weighted shares, diluted | 141.5M | 132.7M |
| Margins and growth | ||
| Net margin | 2.1% | 3.5% |
| Revenue growth, year over year | +6.0% | – |
| Net income growth, year over year | −35.4% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 |
|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 |
| Filing | 10-K | 10-K |
| Reported | Mar 4, 2026 | Jan 13, 2025 |
| Cash and equivalents | $709.6M | $556.8M |
| Accounts receivable | $686.1M | $743.0M |
| Inventory | $118.6M | $115.1M |
| Total current assets | $2.06B | $1.83B |
| Property, plant and equipment | – | $861.9M |
| Goodwill | $879.5M | $852.1M |
| Intangible assets | $12.4M | – |
| Total assets | $5.29B | $4.96B |
| Accounts payable | $457.9M | $401.2M |
| Short-term debt | $23.4M | $9.23M |
| Total current liabilities | $1.05B | $945.4M |
| Long-term debt | $1.08B | $1.09B |
| Total liabilities | $3.61B | $3.43B |
| Shareholders' equity | $1.69B | $1.52B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 |
|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 |
| Filing | 10-K | 10-K |
| Reported | Mar 4, 2026 | Jan 13, 2025 |
| Operating cash flow | $470.5M | $315.0M |
| Depreciation and amortization | $155.7M | $146.3M |
| Dividends paid | – | $0 |
| Investing cash flow | -$214.2M | -$220.5M |
| Financing cash flow | -$103.5M | $24.6M |
| Net change in cash | $152.8M | $119.2M |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 2, 2026 | 140.9M | −1.6% | SEC |
| Aug 7, 2026 | 141.0M | −1.4% | SEC |
| May 1, 2026 | 143.4M | +0.2% | SEC |
| Mar 10, 2026 | 142.9M | +0.1% | SEC |
| Nov 7, 2025 | 143.2M | +0.3% | SEC |
| Aug 4, 2025 | 143.1M | +0.2% | SEC |
| May 2, 2025 | 143.0M | – | SEC |
| Feb 27, 2025 | 142.8M | – | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.